Burant CF, Viswanathan P, Marcinak J, Cao C, Vakilynejad M, Xie B, Leifke E
11 The REWIND CVOT trial reported worse ocular outcomes (requiring photocoagulation, anti-VEGF therapy, or vitrectomy) in patients treated with dulaglutide compared with placebo
Nature Commun
Nevertheless, current evidence supports GLP-1 RAs and multi-agonist formulations as highly promising pharmacotherapies that address the complex, multifactorial pathophysiology of MASLD while simultaneously improving cardiometabolic comorbidities, positioning them as cornerstone treatments in the evolving therapeutic landscape for this prevalent and burdensome disease
Baghdad Sci J 12(1):1419 Adeyanju AO et al (2024) Studies on the use of fermented Parkia biglobosa seeds in the management of induced bacterial conjunctivitis in experimental albino rats ( Rattus albus )
Croarkin reported serving on the advisory board for MindMed